Ex-Enzo Biochem Honcho Wants $10M Under SOX

Law360, New York (May 11, 2009, 12:00 AM EDT) -- The former president of Enzo Biochem Inc. unit Enzo Clinical Labs Inc. is seeking more than $10 million in an arbitration claim related to his termination and what he says is retaliation against him under the Sarbanes-Oxley Act.

In a filing Friday with the U.S. Securities and Exchange Commission, parent company Enzo Biochem Inc. said that Shahram K. Rabbani, who is a member of its board, had submitted a demand for arbitration on April 30 to the American Arbitration Association.

The claim alleges that Enzo Biochem...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.